Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001829126-25-005279
Filing Date
2025-07-22
Accepted
2025-07-22 16:55:27
Documents
13
Period of Report
2025-07-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A blackhawkacq_8ka.htm   iXBRL 8-K/A 35275
  Complete submission text file 0001829126-25-005279.txt   257544

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bkhau-20250708.xsd EX-101.SCH 4063
3 XBRL DEFINITION FILE bkhau-20250708_def.xml EX-101.DEF 27156
4 XBRL LABEL FILE bkhau-20250708_lab.xml EX-101.LAB 37607
5 XBRL PRESENTATION FILE bkhau-20250708_pre.xml EX-101.PRE 25776
15 EXTRACTED XBRL INSTANCE DOCUMENT blackhawkacq_8ka_htm.xml XML 8517
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 8-K/A | Act: 34 | File No.: 001-41984 | Film No.: 251140837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)